Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
01332 TOUYUN BIOTECH
RT Nominal up0.169 +0.007 (+4.321%)
Latest  |  Final  |  Interim
Non-current Assets
2025/12 - Final
HKD(K$)
%Chg
(Compare to Final)
2024/12
HKD(K$)
2023/12
HKD(K$)
2022/12
HKD(K$)
2021/12
HKD(K$)
Investment Properties0--0000
Property, plant, equip. & others178,806-11.910%202,980218,379290,570327,361
Land & other Lease Assets63,386-17.890%77,19692,25290,712108,589
Intangible Assets0--002771,624
Interests in Asso. & JCEs0--0000
Other Non-current Assets279,167190.527%96,090134,225184,129318,937

521,35938.561%376,266444,856565,688756,511
Current Assets
2025/12 - Final
HKD(K$)
%Chg
(Compare to Final)
2024/12
HKD(K$)
2023/12
HKD(K$)
2022/12
HKD(K$)
2021/12
HKD(K$)
Inventories18,241-25.804%24,58515,24935,61332,766
Trade Receivables9,461-57.544%22,28427,13941,44566,287
Cash & Bank Balances5,063-68.971%16,31734,493128,09860,198
Other Current Assets65,580-40.848%110,86785,603116,853108,966
Assets Held for Sale0--0000

98,345-43.497%174,053162,484322,009268,217
Current Liabilities
2025/12 - Final
HKD(K$)
%Chg
(Compare to Final)
2024/12
HKD(K$)
2023/12
HKD(K$)
2022/12
HKD(K$)
2021/12
HKD(K$)
Trade Payables7,806-37.692%12,52817,96128,31937,875
S-T Debt & Leases413,27117.536%351,611179,355200,822310,657
Other Current Liabilities170,372-12.109%193,844183,397180,855181,029
Liab asso w/ Assets Held for Sale0--0000

591,4495.998%557,983380,713409,996529,561
Net Current Assets(493,104)28.436%(383,930)(218,229)(87,987)(261,344)
Total Assets Less Current Liabilities28,255--(7,664)226,627477,701495,167
Non-current Liabilities
2025/12 - Final
HKD(K$)
%Chg
(Compare to Final)
2024/12
HKD(K$)
2023/12
HKD(K$)
2022/12
HKD(K$)
2021/12
HKD(K$)
L-T Debt & Leases353-98.930%32,978205,554194,1928,122
Other Non-current Liabilities511--0000

864-97.380%32,978205,554194,1928,122
Capital and Reserves
2025/12 - Final
HKD(K$)
%Chg
(Compare to Final)
2024/12
HKD(K$)
2023/12
HKD(K$)
2022/12
HKD(K$)
2021/12
HKD(K$)
  Share Capital112,2380.000%112,238112,238112,238112,238
  Reserves(163,336)-16.426%(195,438)(113,086)151,721357,679
  Others0--0000
Shareholders' Funds(51,098)-38.584%(83,200)(848)263,959469,917
Non-controlling Interests78,48984.428%42,55821,92119,55017,128
Others0--0000

27,391--(40,642)21,073283,509487,045
Commitments and Contingent Liabilities
2025/12 - Final
HKD(K$)
%Chg
(Compare to Final)
2024/12
HKD(K$)
2023/12
HKD(K$)
2022/12
HKD(K$)
2021/12
HKD(K$)
Commitments----2,7133,9153,8714,708
Contingent Liabilities----0000
Remarks:  Real time quote last updated: 10/04/2026 17:59
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
Security Code
Company Name (Chi/Eng/Keywords)
Industry
Profit / (Loss) Attributable to Shareholders (K$)HKD 26,799
%Change--
EPS / (LPS)HKD 0.010
NBV Per Share ($)HKD -0.018
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2026 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.